Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

• Status: Completed
• Trial end date: 2008-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates the performance and acceptance of Optive versus Hylocomod eyedrops, when administered for one month to patients with mild to moderate dry eye symptoms, with and without contact lenses.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Glycerol; Hyaluronic Acid; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• 18 years or over

• Contact lens wearer, spectacle wearer or non-spectacle wearer

• Mild to severe dry eye symptoms, defined as OSDI score 13 to 100

• Mild to moderate conjunctival staining in each eye and/or mild to moderate corneal staining in each eye

• Best corrected visual acuity of 6/9 in each eye

Exclusion Criteria:

• Previously used Hylocomod or Optive eyedrops

• Systemic allergy or eye allergy

• Systemic disease which might have an ocular component and/or interfere with contact lens wear

• Autoimmune disease which might have an ocular component and/or interfere with contact lens wear

• Systemic medication which might have eye side effects and or interfere with contact lens wear

• Eye infection or use of eye medication